A novel CDH1 germline missense mutation in a sporadic gastric cancer patient in north-east of Italy
暂无分享,去创建一个
V. Canzonieri | R. Seruca | Soraia Melo | S. Geremia | V. De Re | G. Toffoli | J. Figueiredo | R. Cannizzaro | L. Caggiari | M. De Zorzi | J. Simões-Correia | M. Garziera
[1] Guoping Zheng,et al. E-Cadherin/β-Catenin Complex and the Epithelial Barrier , 2011, Journal of biomedicine & biotechnology.
[2] F. Roviello,et al. E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer. , 2011, European journal of cancer.
[3] J. Gu,et al. Modulation of E-cadherin function and dysfunction by N-glycosylation , 2011, Cellular and Molecular Life Sciences.
[4] R. Ribeiro,et al. E-cadherin immunoexpression patterns in the characterisation of gastric carcinoma histotypes , 2010, Journal of Clinical Pathology.
[5] C. Caldas,et al. Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research , 2010, Journal of Medical Genetics.
[6] R. Seruca,et al. E-cadherin mutations and cell motility: a genotype-phenotype correlation. , 2009, Experimental cell research.
[7] G. Berx,et al. The cell-cell adhesion molecule E-cadherin , 2008, Cellular and Molecular Life Sciences.
[8] F. Roviello,et al. E-cadherin and hereditary diffuse gastric cancer. , 2007, Surgery.
[9] E. Parisini,et al. The crystal structure of human E-cadherin domains 1 and 2, and comparison with other cadherins in the context of adhesion mechanism. , 2007, Journal of molecular biology.
[10] B. Fernandez,et al. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. , 2007, JAMA.
[11] B. Boman,et al. Identification of seven novel germline mutations in the human E‐cadherin (CDH1) Gene , 2007, Human mutation.
[12] R. Seruca,et al. A model to infer the pathogenic significance of CDH1 germline missense variants , 2006, Journal of Molecular Medicine.
[13] Hudson H. Freeze,et al. Genetic defects in the human glycome , 2006, Nature Reviews Genetics.
[14] Lian Zhang,et al. CDH1 germline mutation in hereditary gastric carcinoma. , 2004, World journal of gastroenterology.
[15] W. Foulkes,et al. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria , 2004, Journal of Medical Genetics.
[16] H. Höfler,et al. Germline mutations of the E-cadherin(CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patients , 2004, Journal of Medical Genetics.
[17] D. Huntsman,et al. E-cadherin germline missense mutations and cell phenotype: evidence for the independence of cell invasion on the motile capabilities of the cells. , 2003, Human molecular genetics.
[18] Carla Oliveira,et al. Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands. , 2003, Human molecular genetics.
[19] M. Wilkinson,et al. Site-directed mutagenesis of large (13-kb) plasmids in a single-PCR procedure. , 2000, BioTechniques.
[20] S. Ramesh,et al. Reduction in membranous expression of β-catenin and increased cytoplasmic E-cadherin expression predict poor survival in gastric cancer , 1999, British Journal of Cancer.
[21] Anthony E. Reeve,et al. E-cadherin germline mutations in familial gastric cancer , 1998, Nature.
[22] Gerhard Christofori,et al. A causal role for E-cadherin in the transition from adenoma to carcinoma , 1998, Nature.
[23] Heinz Höfler,et al. Mutations of the human E‐cadherin (CDH1) gene , 1998, Human mutation.
[24] S. Jordan,et al. Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival. , 1997, Gastroenterology.
[25] P. Laurén,et al. THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. , 1965, Acta pathologica et microbiologica Scandinavica.